Phio Pharmaceuticals Corp.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$10,826,000 over the previous period. Total operating expenses were $4,492,000.

Profit Margin

Phio Pharmaceuticals Corp. (NASDAQ:PHIOW): Profit margin
2014 71K -8.8M -12394.37%
2015 34K -10.22M -30067.65%
2016 19K -8.99M -47336.84%
2017 15K -12.45M -83013.33%
2018 138K -7.36M -5333.33%
2019 21K -8.84M -42100%
2020 0 -8.79M
2021 0 -13.21M
2022 0 -11.30M
2023 0 -10.82M

PHIOW Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
000021K138K15K19K34K71K
Cost of revenue
6.33M193K192K183K4.3K05.37M06.92M5.68M
Gross profit
-6.33M-193K-192K-183K16.7K138K-5.35M19K-6.89M-5.60M
Operating exp.
Research and development
6.33M7.01M8.88M4.43M4.3M4.32M5.37M5.41M6.92M5.68M
Selling and marketing
0000000000
Total operating expenses
4.49M11.46M13.51M8.79M9.00M7.50M9.38M9.03M10.27M8.89M
Operating income
-10.82M-11.46M-13.51M-8.79M-8.98M-7.36M-14.06M-9.01M-10.23M-8.82M
Other income (expenses), net
-2K-18K224K-1K79K4K-11K21K14K26K
Income before tax
-10.82M-11.48M-13.28M-8.79M-8.90M-7.36M-14.07M-8.99M-10.22M-8.8M
Income tax expense
0-175K-75K-134.29K-67K4K-1.62M-74K-91K-113K
Net income
-10.82M-11.30M-13.21M-8.79M-8.84M-7.36M-12.45M-8.99M-10.22M-8.8M
Earnings per share
Basic EPS
-46.87-9.95-12.36-207.25-230.23-690.24-32.80K-8.80K-93.02K-238.07K
Diluted EPS
-46.76-9.95-12.36-207.25-230.23-690.24-32.80K-8.80K-93.02K-238.07K
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source